The changing landscape of acromegaly - an epidemiological perspective
- PMID: 38337125
- DOI: 10.1007/s11154-024-09875-z
The changing landscape of acromegaly - an epidemiological perspective
Abstract
Acromegaly is a rare disease and thus challenging to accurately quantify epidemiologically. In this comprehensive literature review, we compare different approaches to studying acromegaly from an epidemiological perspective and describe the temporal evolution of the disease pertaining to epidemiological variables, clinical presentation and mortality. We present updated epidemiological data from the population-based Danish cohort of patients with acromegaly (AcroDEN), along with meta-analyses of existing estimates from around the world.Based on this, we conclude that the incidence, prevalence and age at acromegaly diagnosis are all steadily increasing, but with considerable variation between studies. An increased number of incidental cases may contribute to the increase in incidence and age at diagnosis, respectively. The clinical features at presentation are trending toward a milder disease phenotype at diagnosis, and advances in therapeutic options have reduced the mortality of patients with acromegaly to a level similar to that of the general population. Moreover, the underlying cause of death has shifted from cardiovascular to malignant neoplastic diseases.
Keywords: Acromegaly; Epidemiology; Incidence; Mortality; Prevalence; Sex differences.
© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Similar articles
-
Acromegaly incidence, prevalence, complications and long-term prognosis: a nationwide cohort study.Eur J Endocrinol. 2016 Sep;175(3):181-90. doi: 10.1530/EJE-16-0117. Epub 2016 Jun 8. Eur J Endocrinol. 2016. PMID: 27280374
-
Epidemiology of acromegaly: review of population studies.Pituitary. 2017 Feb;20(1):4-9. doi: 10.1007/s11102-016-0754-x. Pituitary. 2017. PMID: 27743174 Free PMC article. Review.
-
Descriptive Epidemiology and Survival Analysis of Acromegaly in Korea.J Korean Med Sci. 2021 Jun 14;36(23):e159. doi: 10.3346/jkms.2021.36.e159. J Korean Med Sci. 2021. PMID: 34128596 Free PMC article.
-
Clinical and Economic Burden of Commercially Insured Patients with Acromegaly in the United States: A Retrospective Analysis.J Manag Care Spec Pharm. 2015 Dec;21(12):1106-12. doi: 10.18553/jmcp.2015.21.12.1106. J Manag Care Spec Pharm. 2015. PMID: 26679960 Free PMC article.
-
[The importance of early diagnosis in acromegaly].Orv Hetil. 2011 May 1;152(18):696-702. doi: 10.1556/OH.2011.29109. Orv Hetil. 2011. PMID: 21498157 Review. Hungarian.
Cited by
-
Psychiatric morbidity in acromegaly: a cohort study and meta-analysis of the literature.Pituitary. 2025 Mar 13;28(2):42. doi: 10.1007/s11102-025-01509-0. Pituitary. 2025. PMID: 40082297 Free PMC article.
-
Prevalence and risk factors of colon polyps and other colonic lesions in acromegaly: Insights from colonoscopy screening.Pituitary. 2025 Apr 1;28(2):44. doi: 10.1007/s11102-025-01513-4. Pituitary. 2025. PMID: 40167828 Free PMC article.
-
Changes in acromegaly comorbidities, treatment, and outcome over three decades: a nationwide cohort study.Front Endocrinol (Lausanne). 2024 Apr 4;15:1380436. doi: 10.3389/fendo.2024.1380436. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 38638137 Free PMC article.
-
Editorial: Cancer risk in patients with acromegaly - is extensive screening needed?Front Endocrinol (Lausanne). 2024 Oct 28;15:1503633. doi: 10.3389/fendo.2024.1503633. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 39534256 Free PMC article. No abstract available.
-
Comparative mortality in pituitary adenomas subtypes: a tertiary referral center study.Endocrine. 2025 Feb;87(2):782-787. doi: 10.1007/s12020-024-04073-y. Epub 2024 Oct 19. Endocrine. 2025. PMID: 39425840 Free PMC article.
References
-
- Fleseriu M, Langlois F, Lim DST, Varlamov EV, Melmed S. Acromegaly: pathogenesis, diagnosis, and management. Lancet Diabetes Endocrinol. 2022;10:804–26. https://doi.org/10.1016/S2213-8587(22)00244-3 . - DOI - PubMed
-
- Dal J, Feldt-Rasmussen U, Andersen M, Kristensen L, Laurberg P, Pedersen L, et al. Acromegaly incidence, prevalence, complications and long-term prognosis: a nationwide cohort study. Eur J Endocrinol. 2016;175:181–90. https://doi.org/10.1530/EJE-16-0117 . - DOI - PubMed
-
- Esposito D, Ragnarsson O, Johannsson G, Olsson DS. Prolonged diagnostic delay in acromegaly is associated with increased morbidity and mortality. Eur J Endocrinol. 2020;182:523–31. https://doi.org/10.1530/EJE-20-0019 . - DOI - PubMed
-
- Petrossians P, Daly AF, Natchev E, Maione L, Blijdorp K, Sahnoun-Fathallah M, et al. Acromegaly at diagnosis in 3173 patients from the Liège Acromegaly Survey (LAS) Database. Endocr Relat Cancer. 2017;24:505–18. https://doi.org/10.1530/ERC-17-0253 . - DOI - PubMed - PMC
-
- Caron P, Brue T, Raverot G, Tabarin A, Cailleux A, Delemer B, et al. Signs and symptoms of acromegaly at diagnosis: the physician’s and the patient’s perspectives in the ACRO-POLIS study. Endocrine. 2019;63:120–9. https://doi.org/10.1007/S12020-018-1764-4 . - DOI - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources